Biomedical research center advancing drug discovery and personalized medicine
Helmholtz Munich is a 2,500+ person nonprofit research institution focused on diabetes, lung disease, allergies, and environmental health. The tech stack reflects dual infrastructure demands: deep learning (PyTorch, JAX, scikit-learn) and high-performance computing (Lustre, BeeGFS, InfiniBand, OpenStack) for genomics and microscopy workloads, paired with enterprise systems (SAP S/4HANA, LIMS) to coordinate research across 18 federated centers. Active hiring in research roles and explicit pain points around LIMS fragmentation and security governance signal infrastructure modernization underway.
Notable leadership hires: Head Controlling
Helmholtz Munich develops biomedical solutions addressing metabolic, respiratory, and immune diseases with translational research spanning drug discovery, stem cell biology, and epigenetics. The organization operates as part of the Helmholtz Association, Germany's largest public research body, and pursues industry-academia partnerships to accelerate the path from bench discovery to clinical deployment. Current project focus includes quantum microscopy, single-cell foundation models, RNA therapeutics delivery, and digital pathology — all supported by a heterogeneous compute and data infrastructure spanning cloud, on-premise HPC, and LIMS systems serving multiple research centers.
PyTorch, JAX, scikit-learn (ML), PostgreSQL and SQL Server (data), Lustre and BeeGFS (HPC storage), InfiniBand (networking), OpenStack (cloud), LIMS (lab management), and SAP S/4HANA (enterprise).
Current projects include quantum-enhanced microscopy, single-cell AI models for pathology, RNA therapeutic delivery, deep visual proteomics, and RNA splicing research in pediatric disease contexts.
Other companies in the same industry, closest in size